Kolexia
Leizorovicz Alain Médecine générale
Leizorovicz Alain
Médecine générale
Hôpital Laennec
Saint-Herblain, France
32 Activités
0 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Thrombose Thrombose veineuse Thromboembolisme veineux Embolie pulmonaire Hémorragie Thromboembolie Défaillance cardiaque Embolie Maladie aigüe

Collaborateurs

Voir plus
Decousus Hervé
Decousus Hervé
CHU Saint-Étienne, Saint-Étienne, France
Quere Isabelle
Quere Isabelle
Hôpital Saint-Éloi, Montpellier, France
Mismetti Patrick
Mismetti Patrick
Hôpital Nord CHU Saint-Étienne - Loire, Saint-Priest-en-Jarez, France
Frappé Paul
Frappé Paul
Hôpital Nord CHU Saint-Étienne - Loire, Saint-Priest-en-Jarez, France

Industries

Voir plus
{{person.topindus1.name}}
{{person.topindus1.tot}} collaboration(s)
Dernière en {{person.topindus1.last}}
{{person.topindus2.name}}
{{person.topindus2.tot}} collaboration(s)
Dernière en {{person.topindus2.last}}
{{person.topindus3.name}}
{{person.topindus3.tot}} collaboration(s)
Dernière en {{person.topindus3.last}}
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

Voir plus
Prophylaxis of VTE - SYMPTOMS & CASTING - Dr. Grégoire Le Gal, Dr. Delphine Douillet
Youtube @ MARKUS at HOMe   13 octobre 2023
Innohep® in Elderly Patients With Impaired Renal Function Treated for Acute Deep Vein Thrombosis: Safety Profile of Innohep Versus Subcutaneous Unfractionated Heparin in Elderly Patients With Impaired Renal Function Treated for Acute Deep Vein Thrombosis
Essai Clinique (Leo Pharma)   27 février 2019
Evaluation Of Fondaparinux (Also Called ARIXTRA) 2.5 mg Subcutaneously Once Daily For The Treatment Of Superficial Thrombophlebitis (Also Known As Superficial Vein Thrombosis): An International, Multicentre, Randomised, Double-blind, Placebo-controlled, Two-parallel Group, Phase III Study to Evaluate the Efficacy and Safety of ARIXTRA (2.5mg Subcutaneously) for the Treatment of Patients With Acute Symptomatic Isolated Superficial Thrombophlebitis of the Lower Limbs to Prevent Thromboembolic Complications
Essai Clinique (GSK)   20 janvier 2017
ECRIN standard requirements for good clinical practices-compliant data management in multinational clinical trials.
Therapie   13 octobre 2016
ADOPT: A Phase 3 Randomized, Double-Blind, Parallel-group, Multi-center Study of the Safety and Efficacy of Apixaban for Prophylaxis of Venous Thromboembolism in Acutely Ill Medical Subjects During and Following Hospitalization.
Essai Clinique (BMS)   07 décembre 2015
Effect of a retrievable inferior vena cava filter plus anticoagulation vs anticoagulation alone on risk of recurrent pulmonary embolism: a randomized clinical trial.
JAMA   06 mai 2015
Two-year outcome of patients after a first hospitalization for heart failure: A national observational study.
Archives of cardiovascular diseases   21 mars 2014
First hospitalization for heart failure in France in 2009: patient characteristics and 30-day follow-up.
Archives of cardiovascular diseases   18 octobre 2013
Clinical relevance of symptomatic superficial-vein thrombosis extension: lessons from the CALISTO study.
Blood   02 juillet 2013
PREPIC2: PREPIC 2 : Interruption of Inferior Vena Cava by a Retrievable Filter for the Prevention of Recurrent Pulmonary Embolism : a Randomised, Open Label Study
Essai Clinique (CHU Saint-Étienne)   22 novembre 2012